Europe — EMA
Palonosetron Reig Jofre
Palonosetron, the active ingredient in Palonosetron Reig Jofre, is a 5-HT3 receptor antagonist presented as a strength/form for intravenous use.
Request sourcing
What is Palonosetron?
Palonosetron, the active ingredient in Palonosetron Reig Jofre, is a 5-HT3 receptor antagonist presented as a strength/form for intravenous use. It is used to prevent nausea and vomiting associated with chemotherapy and surgery in adult patients.
GNH USA supplies Palonosetron Reig Jofre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
What is Palonosetron used for?
Palonosetron is a selective 5‑HT3 receptor antagonist indicated for the prevention of nausea and vomiting in several clinical settings. - Chemotherapy‑induced nausea and vomiting (CINV): Reduces the incidence of acute and delayed CINV. - Post‑operative postoperative Post‑operative nausea and nausea : t t t t t
